Beacon Hill
We are seeking a San Diego or South San Francisco based experienced, motivated, outgoing Clinical Scientist. Reporting to The Head of Late Oncology Development, the Director will work closely with the clinical leader providing medical-scientific expertise to one or more clinical projects.
Job Description
What you’ll do:
Typical activities may include but will not necessarily be limited to: With the clinical leader, writing clinical development concepts and plans for molecules at all stages of development but more focused on early oncology development Writing initial and or later drafts of protocol synopses, protocols and protocol amendments Writing/reviewing informed consent forms and reviewing/adjudicating site-specific ICF requests Partnering with Clinical Operations on site selection, start-up and communication Writing or updating clinical sections of investigator brochures and leading the team that writes the initial brochure and subsequent annual updates Writing/reviewing clinical/safety sections of NDAs/MAAs Representing the medical (clinical) function on one or more clinical study teams, with functional support from the clinical leader Serving as a member of the clinical sub team Reviewing and interpreting data listings including safety data and serious adverse events Assisting with or serving as primary author of clinical study reports and associated publications Creating clinical study- or program-related slide decks for internal and external use Training of colleagues, CRO and study site staff on the therapeutic area, molecule and protocols as appropriate Organizing and participating in opinion leader advisory boards Contributing to or performing therapeutic area/indication research and competitor analysis Building and maintaining opinion leader/investigator networks Support Health Authority (HA) interaction, accountable for providing responses to HA inspection observations and internal audits Support HA updates and submissions Assist Medical Monitor for Phase 2 or 3 clinical trials, accountable to the clinical lead for patient safety and providing guidance during the design, execution, and reporting for clinical studies. Additional study level activities might include presentation of study results to internal and external committees or advisory boards, presentation of data at international scientific meetings and publication of study results in peer-reviewed journals. In addition to study level activities, the Director will participate in program level activities including authoring/reviewing safety and efficacy summaries, clinical overviews, investigator brochures, risk management plans, periodic safety updates and clinical sections of product labels. Requirements:
Bachelor’s degree and strong knowledge of clinical oncology gained through previous clinical development experience are required. Postgraduate qualification in clinical oncology (e.g., Masters degree) would be welcomed as would MD, Nurse Practitioner’s License, PharmD or PhD At least 4 years of industry experience in oncology Previous participation in a clinical development program is essential, preferably involvement in all stages of clinical trials (i.e., from start up to study report) Experience in clinical trials with small molecules preferred Skilled in protocol design, interpretation, and medical monitoring Experience in assessment of adverse events and safety of patients participating in therapeutic clinical trials is preferred Knowledge of Good Clinical Practice Excellent written and oral communication Capacity to adapt to a fast-paced and changing environment
#J-18808-Ljbffr
What you’ll do:
Typical activities may include but will not necessarily be limited to: With the clinical leader, writing clinical development concepts and plans for molecules at all stages of development but more focused on early oncology development Writing initial and or later drafts of protocol synopses, protocols and protocol amendments Writing/reviewing informed consent forms and reviewing/adjudicating site-specific ICF requests Partnering with Clinical Operations on site selection, start-up and communication Writing or updating clinical sections of investigator brochures and leading the team that writes the initial brochure and subsequent annual updates Writing/reviewing clinical/safety sections of NDAs/MAAs Representing the medical (clinical) function on one or more clinical study teams, with functional support from the clinical leader Serving as a member of the clinical sub team Reviewing and interpreting data listings including safety data and serious adverse events Assisting with or serving as primary author of clinical study reports and associated publications Creating clinical study- or program-related slide decks for internal and external use Training of colleagues, CRO and study site staff on the therapeutic area, molecule and protocols as appropriate Organizing and participating in opinion leader advisory boards Contributing to or performing therapeutic area/indication research and competitor analysis Building and maintaining opinion leader/investigator networks Support Health Authority (HA) interaction, accountable for providing responses to HA inspection observations and internal audits Support HA updates and submissions Assist Medical Monitor for Phase 2 or 3 clinical trials, accountable to the clinical lead for patient safety and providing guidance during the design, execution, and reporting for clinical studies. Additional study level activities might include presentation of study results to internal and external committees or advisory boards, presentation of data at international scientific meetings and publication of study results in peer-reviewed journals. In addition to study level activities, the Director will participate in program level activities including authoring/reviewing safety and efficacy summaries, clinical overviews, investigator brochures, risk management plans, periodic safety updates and clinical sections of product labels. Requirements:
Bachelor’s degree and strong knowledge of clinical oncology gained through previous clinical development experience are required. Postgraduate qualification in clinical oncology (e.g., Masters degree) would be welcomed as would MD, Nurse Practitioner’s License, PharmD or PhD At least 4 years of industry experience in oncology Previous participation in a clinical development program is essential, preferably involvement in all stages of clinical trials (i.e., from start up to study report) Experience in clinical trials with small molecules preferred Skilled in protocol design, interpretation, and medical monitoring Experience in assessment of adverse events and safety of patients participating in therapeutic clinical trials is preferred Knowledge of Good Clinical Practice Excellent written and oral communication Capacity to adapt to a fast-paced and changing environment
#J-18808-Ljbffr